It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Robert Blanks Biography and Net Worth

Insider of Ardelyx

Rob has served as our Chief Regulatory Affairs and Quality Assurance Officer since 2020. Before that, Rob had served as our head of regulatory affairs and quality assurance since August 2013. Rob has over 20 years of experience in the pharmaceutical industry in the quality, regulatory and CMC areas. A majority of this experience has been with small biotech companies, where he has played a critical role in developing companies’ initial drug product candidates, including peptides, monoclonal antibodies and small molecules, from the pre-clinical stage to commercial registration.

Prior to Ardelyx, Rob was vice president of CMC at Flexion Therapeutics where he oversaw the manufacture of the company’s initial two drug product candidates, one of which Zillretta™, is in late Phase 3 development. Prior to Flexion, he was vice president of quality at Idenix Pharmaceuticals, overseeing all quality aspects of the commercial launch of the company’s first product, Tyzeka®. Previous to Idenix, he served as vice president of technical operations for Trine Pharmaceuticals and earlier was vice president of technical operations and founder of Phaedrus Pharmaceuticals. At GelTex Pharmaceuticals, subsequently purchased by Genzyme, he was a key participant in both the quality and regulatory areas in the development and registration of RenaGel®.

What is Robert Blanks' net worth?: The estimated net worth of Robert Blanks is at least $1.60 million as of June 21st, 2024. Mr. Blanks owns 324,331 shares of Ardelyx stock worth more than $1,595,709 as of November 20th. This net worth approximation does not reflect any other investments that Mr. Blanks may own. Additionally, Mr. Blanks receives an annual salary of $590,800.00 as Insider at Ardelyx. Learn More about Robert Blanks' net worth.
How old is Robert Blanks?: Mr. Blanks is currently 64 years old. There are 6 older executives and no younger executives at Ardelyx. Learn More on Robert Blanks' age.
What is Robert Blanks' salary?: As the Insider of Ardelyx, Inc., Mr. Blanks earns $590,800.00 per year. There are 5 executives that earn more than Mr. Blanks. The highest earning executive at Ardelyx is Mr. Michael G. Raab, President, CEO & Director, who commands a salary of $1,030,000.00 per year. Learn More on Robert Blanks' salary.
How do I contact Robert Blanks?: The corporate mailing address for Mr. Blanks and other Ardelyx executives is 34175 ARDENWOOD BOULEVARD SUITE 200, FREMONT CA, 94555. Ardelyx can also be reached via phone at (510) 745-1700 and via email at [email protected]. Learn More on Robert Blanks' contact information.
Has Robert Blanks been buying or selling shares of Ardelyx?: Robert Blanks has not been actively trading shares of Ardelyx during the past quarter. Most recently, Robert Blanks sold 38,000 shares of the business's stock in a transaction on Friday, June 21st. The shares were sold at an average price of $5.96, for a transaction totalling $226,480.00. Following the completion of the sale, the insider now directly owns 324,331 shares of the company's stock, valued at $1,933,012.76. Learn More on Robert Blanks' trading history.
Who are Ardelyx's active insiders?: Ardelyx's insider roster includes Robert Blanks (Insider), Elizabeth Grammer (Insider), Jeffrey Jacobs (Insider), Michael Raab (CEO), David Rosenbaum (Insider), and Scott Sandell (Major Shareholder). Learn More on Ardelyx's active insiders.
Are insiders buying or selling shares of Ardelyx?: In the last year, insiders at the biopharmaceutical company sold shares 46 times. They sold a total of 1,349,920 shares worth more than $9,327,695.68. The most recent insider tranaction occured on November, 11th when CEO Michael Raab sold 2,743 shares worth more than $13,440.70. Insiders at Ardelyx own 5.9% of the company. Learn More about insider trades at Ardelyx.
Information on this page was last updated on 11/11/2024.

Robert Blanks Insider Trading History at Ardelyx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/21/2024	Sell	38,000	$5.96	$226,480.00	324,331
2/20/2024	Sell	5,017	$8.75	$43,898.75	368,186
6/23/2023	Sell	33,333	$3.63	$120,998.79	266,134
10/5/2022	Sell	100,000	$1.50	$150,000.00	195,827
8/26/2022	Sell	21,842	$1.04	$22,715.68	295,827
7/26/2022	Sell	5,188	$0.67	$3,475.96	319,127
2/22/2022	Sell	1,752	$0.67	$1,173.84
9/1/2020	Sell	2,049	$5.58	$11,433.42

Robert Blanks Buying and Selling Activity at Ardelyx

Ardelyx Company Overview

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $4.95

$4.82

$4.96

50 Day Range

MA: $5.88

$4.50

$6.93

2 Week Range

Now: $4.95

$4.06

$10.13

Volume

445,525 shs

Average Volume

4,955,027 shs

Market Capitalization

$1.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Tesla Execs are Freaking Out

From Angel Publishing | Ad

Click here to get the details.

Robert Blanks Biography and Net Worth

What is Robert Blanks' net worth?

How old is Robert Blanks?

What is Robert Blanks' salary?

How do I contact Robert Blanks?

Has Robert Blanks been buying or selling shares of Ardelyx?

Who are Ardelyx's active insiders?

Are insiders buying or selling shares of Ardelyx?